Abstract Purpose of Review To discuss current knowledge and recent findings regarding the
epidemiology of hepatocellular carcinoma (HCC) in the USA. Recent Finding The US …

Autoimmune hepatitis (AIH) is an unresolving progressive liver disease of unknown etiology
characterized by hypergammaglobulinemia, autoantibodies detection and interface …

Autoimmune hepatitis (AIH) was the first liver disease for which an effective therapeutic
intervention, corticosteroid treatment, was convincingly demonstrated in controlled clinical …

Paediatric autoimmune liver disease is characterized by inflammatory liver histology,
circulating autoantibodies, and increased levels of IgG, in the absence of a known etiology …

We read with interest the article:“Autoimmune hepatitis developing after coronavirus disease
2019 (COVID-19) Vaccine: Causality or casualty? ˮ by Bril F. et al. 1 and the comment to the …

Liver cancer, of which hepatocellular carcinoma (HCC) is the dominant variety, represents
the fourth leading cause of cancer deaths worldwide. The geographic map of the incidence …

Guiqiang Wang1, 18· Atsushi Tanaka2· Hong Zhao1, 1 8· Jidong Jia3· Xiong Ma4· Kenichi
Harada5· Fu‑Sheng Wang6· Lai Wei7· Qixia Wang4· Ying Sun6· Yuan Hong1· Huiying …

Autoimmune hepatitis (AIH) is a relatively rare non-resolving chronic liver disease, which
mainly affects women. It is characterized by hypergammaglobulinemia, circulating …

Background & Aims Treatment options remain limited for patients with autoimmune hepatitis
(AIH), while there are still concerns over the consequences of long-term corticosteroid use. A …

Autoimmune hepatitis (AIH) fulfills the generally accepted contemporary criteria of an
autoimmune liver disease: the presence of autoantibodies and autoreactive T cells, a female …